Elanco Animal Health (ELAN) FCF Margin (2017 - 2026)
Elanco Animal Health (ELAN) reported FCF Margin of 2.77% for Q1 2026, up 301.0% on a YoY basis from 0.69% in Q1 2025, and down 168.93% sequentially from 4.02% in Q4 2025.
Elanco Animal Health (ELAN) FCF Margin (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of FCF Margin data on file, last reported at 2.77% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 301.0% year-over-year to 2.77%; the trailing twelve-month figure through Mar 2026 stood at 6.44% (down 140.0% YoY), and the FY2025 full-year result was 6.02%, down 285.0% from the prior year.
- FCF Margin eased to 2.77% in Q1 2026, from 4.02% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 22.21% in Q2 2022 to a low of 13.44% in Q1 2023.
- A 5-year average of 5.75% and a median of 11.17% in 2025 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 1771 bps in 2023, while the deepest fall reached 2042 bps in 2023.
- Tracing ELAN's FCF Margin over 5 years: stood at 6.5% in 2022, then surged by 272 bps to 11.21% in 2023, then grew by 14 bps to 12.75% in 2024, then slumped by 68 bps to 4.02% in 2025, then tumbled by 169 bps to 2.77% in 2026.
- Business Quant data shows ELAN's FCF Margin at 2.77% in Q1 2026, 4.02% in Q4 2025, and 11.17% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.77% |
| Dec 31, 2025 | 4.02% |
| Sep 30, 2025 | 11.17% |
| Jun 30, 2025 | 14.50% |
| Mar 31, 2025 | -5.78% |
| Dec 31, 2024 | 12.75% |
| Sep 30, 2024 | 11.65% |
| Jun 30, 2024 | 14.02% |
| Mar 31, 2024 | -1.83% |
| Dec 31, 2023 | 11.21% |
| Sep 30, 2023 | 15.45% |
| Jun 30, 2023 | 1.80% |
| Mar 31, 2023 | -13.44% |
| Dec 31, 2022 | -6.50% |
| Sep 30, 2022 | 14.91% |
| Jun 30, 2022 | 22.21% |
| Mar 31, 2022 | -5.63% |
| Dec 31, 2021 | 6.74% |
| Sep 30, 2021 | 7.96% |
| Jun 30, 2021 | 12.13% |